E.R. Squibb, 1854

1854 journal belonging to E.R. Squibb, which includes his development of an ether-distilling process, as well as daily entries with descriptions of his laboratory work. A fire in 1858 in Squibb's laboratory damaged the journal.Otis Historical Archives, National Museum of Health and Medicine, AFIP, Photo: © Jason varney | Varneyphoto.com Before Edward R. Squibb (1819-1900) founded the drug company that bore his n

Written byMichael Rhode
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Before Edward R. Squibb (1819-1900) founded the drug company that bore his name, he was a United States Navy doctor who was unimpressed by the quality of medicines available on ships. In 1854, he developed a method of safely distilling ether for use as an anesthetic. He did not patent his method, but instead published it freely. His daily journal, shown here, documented his experiments with ether and chloroform in Philadelphia.

On November 25, 1854, a typical day, he visited bookstores with famed naturalist Joseph Leidy, and then attended a medical lecture. Squibb noted: "Finally an amputation of the thigh in a middle-age woman. Done pretty well - with Ether." This operation, using the ether that made it successful, would be performed frequently in the following decade.

In 1858, the same year he founded E.R. Squibb, ether caused a disastrous fire in his laboratory; the fire burned both Squibb and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform